Publication | Closed Access

Photothermal therapy mediated by phase-transformation nanoparticles facilitates delivery of anti-PD1 antibody and synergizes with antitumor immunotherapy for melanoma

NanoparticlesNanomedicineEngineeringTherapeutic NanomaterialsPhotodynamic TherapyImmunologyPhase-transformation NanoparticlesNano-drug DeliveryTumor TargetingBiomedical EngineeringAnti-pd1 AntibodyImmunotherapyPhotothermal TherapyHealth Sciences